Targeting malaria parasites with novel derivatives of azithromycin
IntroductionThe spread of artemisinin resistant Plasmodium falciparum parasites is of global concern and highlights the need to identify new antimalarials for future treatments. Azithromycin, a macrolide antibiotic used clinically against malaria, kills parasites via two mechanisms: ‘delayed death’...
Main Authors: | Amy L. Burns, Brad E. Sleebs, Maria Gancheva, Kimberley T. McLean, Ghizal Siddiqui, Henrietta Venter, James G. Beeson, Ryan O’Handley, Darren J. Creek, Shutao Ma, Sonja Frölich, Christopher D. Goodman, Geoffrey I. McFadden, Danny W. Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.1063407/full |
Similar Items
-
Therapeutic study of rosacea by Azithromycin and Metronidazole
by: Naseer A. Al-harchan
Published: (2010-01-01) -
The effect of azithromycin on sputum inflammatory markers in bronchiectasis
by: L. C. Terpstra, et al.
Published: (2023-04-01) -
Manuka honey in combination with azithromycin shows potential for improved activity against Mycobacterium abscessus
by: Victoria C. Nolan, et al.
Published: (2022-12-01) -
AZITHROMYCIN IN THERAPY OF BACTERIAL RHINOSINUSITES
by: A. A. Krivopalov, et al.
Published: (2017-07-01) -
Comparison of therapeutic effects of topical azithromycin versus topical azithromycin with systemic doxycycline on posterior blepharitis
by: Mohamed A. H Ibrahim, et al.
Published: (2023-01-01)